Publication Name	World Journal of Biological Chemistry
Manuscript ID	106850
Country	Greece

Received	2025-03-09 07:13
Peer-Review Started	2025-03-09 07:14
To Make the First Decision
Return for Revision	2025-03-19 09:55
Revised	2025-03-31 19:04
Second Decision	2025-04-09 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-04-09 08:59
Articles in Press	2025-04-09 08:59
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-04-16 04:06
Typeset the Manuscript	2025-05-27 03:00
Publish the Manuscript Online	2025-05-30 02:05

ISSN	1949-8454 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Neurosciences
Manuscript Type	Minireviews
Article Title	Stem cell therapy for Parkinson’s disease: A new hope for neural regeneration
Manuscript Source	Invited Manuscript
All Author List	Yasmin Garkani Mokhtari, Irene Varnava, Kosmas Kyrgiannis, Vasiliki Ampatsidou and Dimitrios Giakoumettis
Funding Agency and Grant Number
Corresponding Author	Dimitrios Giakoumettis, Consultant, MD, PhD, Post Doctoral Researcher, Department of Neurosurgery, Agios Savvas, General Anticancer Oncological Hospital, 171 Alexandras Avenue, Athens 11522, Attikí, Greece. dgiakoumettis@gmail.com
Key Words	Stem cells; Parkinson’s disease; Induced pluripotent stem cells; Human pluripotent stem cells; Adult stem cells
Core Tip	Parkinson’s disease (PD) is a neurodegenerative disorder caused by the loss of dopamine neurons in the substantia nigra. To date, there is no treatment for PD while stem cell therapy represents a new therapeutic approach to restore lost neural function. The manuscript focuses on the potential of stem cell therapy, particularly induced pluripotent stem cells (iPSCs) and human pluripotent stem cells, in treating PD, offering potential for neuronal replacement and restoration of brain function. iPSCs are derived from reprogramming adult cells, which are genetically compatible and cause reduced immune rejection, overcoming ethical concerns associated with embryonic stem cells.
Publish Date	2025-05-30 02:05
Citation	<p>Mokhtari YG, Varnava I, Kyrgiannis K, Ampatsidou V, Giakoumettis D. Stem cell therapy for Parkinson’s disease: A new hope for neural regeneration. <i>World J Biol Chem</i> 2025; 16(2): 106850</p>
URL	https://www.wjgnet.com/1949-8454/full/v16/i2/106850.htm
DOI	https://dx.doi.org/10.4331/wjbc.v16.i2.106850

Full Article (PDF)	WJBC-16-106850-with-cover.pdf
Manuscript File	106850_Auto_Edited_081852.docx
Answering Reviewers	106850-answering-reviewers.pdf
Audio Core Tip	106850-audio.mp3
Conflict-of-Interest Disclosure Form	106850-conflict-of-interest-statement.pdf
Copyright License Agreement	106850-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	106850-non-native-speakers.pdf
Peer-review Report	106850-peer-reviews.pdf
Scientific Misconduct Check	106850-scientific-misconduct-check.png
Scientific Editor Work List	106850-scientific-editor-work-list.pdf
CrossCheck Report	106850-crosscheck-report.pdf